# Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy

> **NCT02066974** · — · UNKNOWN · sponsor: **China Medical University, China** · enrollment: 45 (estimated)

## Conditions studied

- Circulating Neoplastic Cells
- Adverse Effect of Radiation Therapy
- Fatal Outcome

## Interventions

- **GENETIC:** hepatoma requiring radiotherapy

## Key facts

- **NCT ID:** NCT02066974
- **Lead sponsor:** China Medical University, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2015-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02066974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02066974, "Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02066974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*